Klebsiella pneumoniae vaccine studies in animal models

Piperaki, 2017, Klebsiella pneumoniae: virulence, biofilm and antimicrobial resistance, Pediatr Infect Dis J, 36, 1002, 10.1097/INF.0000000000001675 Martin, 2018, Colonization, infection, and the accessory genome of Klebsiella pneumoniae, Front Cell Infect Microbiol, 8, 10.3389/fcimb.2018.00004 Xu, 2017, Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae, Ann Clin Microbiol Antimicrob, 16, 18, 10.1186/s12941-017-0191-3 Samaha-Kfoury, 2003, Recent developments in lactamases and extended spectrum lactamases, BMJ, 327, 1209, 10.1136/bmj.327.7425.1209 Kahraman, 2017, The antibiotic resistance patterns of Klebsiella pneumoniae clinic isolates: a comprehensive meta-analysis, Open J Bacteriol, 1, 21, 10.17352/ojb.000005 Malathi, 2019, Identification of potential inhibitors for Klebsiella pneumoniae carbapenemase-3: a molecular docking and dynamics study, J Biomol Struct Dyn, 37, 4601, 10.1080/07391102.2018.1556737 Miryala, 2020, Role of SHV-11, a class A β-lactamase, gene in multidrug resistance among Klebsiella pneumoniae strains and understanding its mechanism by gene network analysis, Microb Drug Resist, 2019 Assoni, 2021, Current stage in the development of Klebsiella pneumoniae vaccines, Infect Dis Ther, 10.1007/s40121-021-00533-4 Choi, 2019, Progress towards the development of Klebsiella vaccines, Expert Rev Vaccines, 18, 681, 10.1080/14760584.2019.1635460 Ahmad, 2012, Development of immunization trials against Klebsiella pneumoniae, Vaccine, 30, 2411, 10.1016/j.vaccine.2011.11.027 Pletz, 2016, Vaccines against major ICU pathogens: where do we stand?, Curr Opin Crit Care, 22, 470, 10.1097/MCC.0000000000000338 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ, 339, 10.1136/bmj.b2700 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, 10.1371/journal.pmed.1000097 Mizgerd, 2008, Animal models of human pneumonia, Am J Physiol Cell Mol Physiol, 294, L387, 10.1152/ajplung.00330.2007 Weinberger, 2008, Biology of immune responses to vaccines in elderly persons, Clin Infect Dis, 46, 1078, 10.1086/529197 He, 2010, Emerging vaccine informatics, J Biomed Biotechnol, 2010, 1 Rappuoli, 2016, Reverse vaccinology 2.0: human immunology instructs vaccine antigen design, J Exp Med, 213, 469, 10.1084/jem.20151960 Zargaran, 2020, B cell epitopes of four fimbriae antigens of Klebsiella pneumoniae: a comprehensive in silico study for vaccine development, Int J Pept Res Therapeut Rostamian, 2020, Immunoinformatics and molecular dynamics studies to predict T-cell-specific epitopes of four Klebsiella pneumoniae fimbriae antigens, J Biomol Struct Dyn, 1 Nemati Zargaran, 2021, Detecting the dominant T and B epitopes of Klebsiella pneumoniae ferric enterobactin protein (FepA) and introducing a single epitopic peptide as vaccine candidate, Int J Pept Res Therapeut, 27, 2209, 10.1007/s10989-021-10247-3 Jones, 1984, Vaccination against 77 capsular types of Klebsiella aerogenes with polyvalent Klebsiella vaccines, J Med Microbiol, 18, 413, 10.1099/00222615-18-3-413 Roe, 1984, Vaccination against Klebsiella aerogenes, J Hyg, 93, 355, 10.1017/S0022172400064913 Libon, 2002, Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies, Vaccine, 20, 2174, 10.1016/S0264-410X(02)00149-4 Lee, 2015, Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity, Exp Mol Med, 47, e183, 10.1038/emm.2015.59 Hegerle, 2018, Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa, PLoS One, 13, 10.1371/journal.pone.0203143 Rostamian, 2018, Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model, Parasitol Res, 117, 2949, 10.1007/s00436-018-5991-7 Sarreshteh, 2017, Route of infection affects pathogenicity of leishmania major in BALB/c mice, J Med Microbiol Infect Dis, 5, 26 LimmaTech Biologics, 2021, Safety and immunogenicity of a Klebsiella pneumoniae tetravalent bioconjugate vaccine (Kleb4V), ClinicalTrialsGov Lorenzo-Gomez, 2021, ICS 2021 melbourne online scientific programme, Neurourol Urodyn, 40, S151 Chhibber, 2005, Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats, Indian J Exp Biol, 43, 40 Chhibber, 1995, Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia, Vaccine, 13, 179, 10.1016/0264-410X(95)93133-T Feldman, 2019, A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae, Proc Natl Acad Sci USA, 116, 18655, 10.1073/pnas.1907833116 Jain, 2015, Alginate microparticles loaded with lipopolysaccharide subunit antigen for mucosal vaccination against Klebsiella pneumoniae, Biologicals, 43, 195, 10.1016/j.biologicals.2015.02.001 Nimier, 1999, Protective effects of RU 41740, a bacterial immunomodulator, against experimental infections: induction of cytokine and immunoglobulin release in mice after oral administration, Int J Immunopharm, 21, 561, 10.1016/S0192-0561(99)00034-X Peng, 2021, Production of a promising biosynthetic self-assembled nanoconjugate vaccine against Klebsiella pneumoniae serotype O2 in a general Escherichia coli host, Adv Sci (Weinheim, Baden-Wurttemberg, Ger, 8 Ravinder, 2020, A synthetic carbohydrate-protein conjugate vaccine candidate against Klebsiella pneumoniae serotype K2, J Org Chem, 85, 15964, 10.1021/acs.joc.0c01404 Seeberger, 2017, A semi-synthetic glycoconjugate vaccine candidate for carbapenem-resistant Klebsiella pneumoniae, Angew Chem Int Ed Engl, 56, 13973, 10.1002/anie.201700964 Babu, 2017, Evaluation of recombinant multi-epitope outer membrane protein-based Klebsiella pneumoniae subunit vaccine in mouse model, Front Microbiol, 8, 10.3389/fmicb.2017.01805 Hussein, 2018, Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model, Microb Pathog, 119, 12, 10.1016/j.micpath.2018.04.004 Kumar, 2020, Early cytokine response to lethal challenge of Klebsiella pneumoniae averted the prognosis of pneumonia in FyuA immunized mice, Microb Pathog, 144, 10.1016/j.micpath.2020.104161 Lavender, 2005, Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease, Int J Med Microbiol, 295, 153, 10.1016/j.ijmm.2005.04.001 Robert, 1982, An attempt to localize the vaccinating power of Klebsiella pneumoniae ribosomal preparations using saccharose-gradient ultracentrifugation, Microbiol Immunol, 26, 941, 10.1111/j.1348-0421.1982.tb00240.x Robert, 1981, On the immunogenicity of ribosomes and ribosomal proteins isolated from Klebsiella pneumoniae and Streptococcus pneumoniae, Microbiol Immunol, 25, 183, 10.1111/j.1348-0421.1981.tb00021.x Rodrigues, 2020, Development and evaluation of a new recombinant protein vaccine (YidR) against Klebsiella pneumoniae infection, Vaccine, 38, 4640, 10.1016/j.vaccine.2020.03.057 Singh, 2001, Potential of Klebsiella pneumoniae cytotoxin toxoid as vaccine against klebsiellosis in rabbits and mice, Vaccine, 19, 4505, 10.1016/S0264-410X(01)00187-6 Cryz, 1986, Immunization against fatal experimental Klebsiella pneumoniae pneumonia, Infect Immun, 54, 403, 10.1128/iai.54.2.403-407.1986 Cryz, 1984, Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide, Infect Immun, 45, 139, 10.1128/iai.45.1.139-142.1984 Malachowa, 2019, Vaccine protection against multidrug-resistant Klebsiella pneumoniae in a nonhuman primate model of severe lower respiratory tract infection, mBio, 10, 10.1128/mBio.02994-19 Roe, 1989, Immunoprotective extracellular polysaccharides of Klebsiella aerogenes capsular type K1, expressed in Escherichia coli, FEMS Microbiol Immunol, 1, 253, 10.1111/j.1574-6968.1989.tb02390.x Chathley, 1996, Lipopolysaccharide-induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae, Folia Microbiol, 41, 373, 10.1007/BF02814718 Clements, 2008, Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections, Vaccine, 26, 5649, 10.1016/j.vaccine.2008.07.100 Rani, 1990, Protection against Klebsiella pneumoniae induced lobar pneumonia in rats with lipopolysaccharide and related antigens, Can J Microbiol, 36, 885, 10.1139/m90-153 Cooper, 1982, Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens, Aust J Exp Biol Med Sci, 60, 629, 10.1038/icb.1982.65 Kuenen, 1994, Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice, FEMS Immunol Med Microbiol, 8, 69, 10.1111/j.1574-695X.1994.tb00427.x Deng, 2004, CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection, J Immunol, 173, 5148, 10.4049/jimmunol.173.8.5148 Karaolis, 2007, Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia, Infect Immun, 75, 4942, 10.1128/IAI.01762-06 Wu, 2020, Nanoparticle reinforced bacterial outer-membrane vesicles effectively prevent fatal infection of carbapenem-resistant Klebsiella pneumoniae, Nanomedicine, 24 Ahmad, 2012, Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae, Infect Dis Rep, 4, 128, 10.4081/idr.2012.e33 Hsieh, 2013, Klebsiella pneumoniae peptidoglycan-associated lipoprotein and murein lipoprotein contribute to serum resistance, antiphagocytosis, and proinflammatory cytokine stimulation, J Infect Dis, 208, 1580, 10.1093/infdis/jit384 Kurupati, 2011, Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice, Clin Vaccine Immunol, 18, 82, 10.1128/CVI.00275-10 Twentyman, 2020, A murine model demonstrates capsule-independent adaptive immune protection in survivors of Klebsiella pneumoniae respiratory tract infection, Dis Model Mech, 13, 10.1242/dmm.043240